Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Mar 25, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a common issue with a monitoring method called cardiotocography (CTG), which is used to check the well-being of babies during labor. Sometimes, the CTG recordings can lose signal or become unclear, which can lead to confusion and unnecessary medical interventions. This trial aims to gather new data on how often these signal losses happen and their impact, as the last major research on this topic was done over a decade ago.

Women who are at least 18 years old and are receiving care at a hospital during labor in February 2024 may be eligible to participate in this study, as long as their pregnancy has reached at least 37 weeks. If they decide to join, they will help researchers understand the effectiveness of CTG monitoring better. It's important to note that this study is currently recruiting participants, and it is focused specifically on adult women who have undergone CTG during labor.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adult female (≥ 18 years old)
• • Patient treated at a hospital between February 1, 2024 and February 28, 2024
• • Having undergone cardiotocography in the labor and delivery room
• • Gestational age at delivery \>36 weeks
• Exclusion Criteria:
• • Patient who has expressed opposition to the use of medical record data
• • Patient without CTG
• • Gestational age at delivery \<36 weeks